In type 1 diabetes mellitus (T1DM), the body attacks the pancreas insulin-producing beta cells and overloads the bloodstream with excess glucose
In large peerreviewed trials, people under medical care achieved doubledigit weight loss over roughly 72 weeks
Hernandez AF, Green JB, Janmohamed S et al (2018) Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (harmony outcomes): a double-blind, randomised placebo-controlled trial
Tirzepatide's most common adverse effects are also gastrointestinal, with nausea (12-22% depending on dose), diarrhea (12-16%), vomiting (6-10%), and constipation (5-7%) reported in clinical trials
However, combining supplements with Semaglutide or Tirzepatide injections requires careful consideration to ensure safety and effectiveness